AS 2639-1994

1 - AS 2639-1994 LAMINAR FLOW CYTOTOXIC DRUG SAFETY CABINETS - INSTALLATION AND USE
4 - PREFACE
5 - CONTENTS
6 - FOREWORD
7 - 1 SCOPE
7 - 2 REFERENCED DOCUMENTS
7 - 3 TERTIARY BARRIER
7 - 4 SECONDARY BARRIER
7 - 4.1 General
7 - 4.2 Asepsis
11 - 4.3 Containment
11 - 4.4 Services
11 - 4.5 Location of the cytotoxic drug safety cabinet
11 - 4.6 Ergonomics
12 - 4.7 Housekeeping and cleaning
12 - 4.8 Spillage
12 - 4.9 Maintenance
13 - 4.10 Inactivators
13 - 5 PRIMARY BARRIER
13 - 5.1 General
13 - 5.2 Cabinet certification
13 - 5.3 User instruction
13 - 5.4 Protective garments
13 - 5.5 Function checks
14 - 5.6 Pre-operational measures
14 - 5.7 Operation
14 - 5.8 Decontamination
15 - 5.9 Post-installation inspection and testing
16 - APPENDIX A - CLEAN-UP PROCEDURE FOLLOWING SPILLAGE IN ROOMS FORMING THE SECONDARY BARRIER
16 - A1 SCOPE
16 - A2 APPLICATION
16 - A3 PROCEDURE
17 - APPENDIX B - SUITABLE PROCEDURE FOR THE SEALING AND SAFE REMOVAL OF CABINET EXHAUST HEPA FILTERS
17 - B1 SCOPE
17 - B2 PROCEDURE
19 - APPENDIX C - CLEAN-UP PROCEDURE FOLLOWING SPILLAGE IN THE CABINET
19 - C1 SCOPE
19 - C2 PROCEDURE
20 - APPENDIX D - PROCEDURE FOR DECONTAMINATION OF CABINET AND REASSEMBLY
20 - D1 SCOPE
20 - D2 APPLICATION
20 - D3 PROCEDURE FOR DECONTAMINATION
20 - D4 PROCEDURE FOR REASSEMBLY
21 - BIBLIOGRAPHY

Sets out recommended practices for the installation, operation, maintenance, decontamination and inspection of open-fronted laminar flow cytotoxic drug safety cabinets.

This Standard sets out recommended practices for the installation, operation, maintenance, decontamination and inspection of open-fronted laminar flow cytotoxic drug safety cabinets as specified in AS 2567.NOTE: Although the cabinets are intended specifically for handling injectable cytotoxic drugs, they may have wider application in the handling of other hazardous drugs and materials. These applications may require additional precautions.

First published as AS 2639-1983.
Second edition 1994.